Breaking News Instant updates and real-time market news.

GNSS

Genasys

$7.00 /

-0.47 (-6.29%)

 08:40
02/17/21
 02/17
08:40
 02/17/21
08:40

Genasys awarded software services contract from Spain MOI

Genasys announced a four-year contract to provide software services for the Spain Ministry of the Interior, a department of the government responsible for public safety, national security, law enforcement, immigration and civil defense. The EECC Article 110 initiative currently directs all EU countries to implement a public warning system that delivers geo-located emergency communications to all mobile phones through every mobile carrier network in each member state by June 2022.

  • 16

    Mar

GNSS Genasys
$7.00 /

-0.47 (-6.29%)

10/13/20 Northland
Genasys initiated with an Outperform at Northland

TODAY'S FREE FLY STORIES

Initiation
Lumos Pharma initiated with a Buy at JonesTrading » 07:13
04/13/21
04/13
07:13
04/13/21
07:13
LUMO

Lumos Pharma

$10.99 /

-0.32 (-2.83%)

JonesTrading analyst Lina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

03/21/21
Lumos Pharma says data shows greater GH response in PGHD from LUM-201
03/04/21
Lumos Pharma announces results of data analyses from PGHD studies
11/10/20
Lumos initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in PGHD
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

03/11/21 Stifel
Lumos Pharma upgraded to Buy from Hold at Stifel
12/03/20
Fly Intel: Top five analyst initiations
12/03/20 Cantor Fitzgerald
Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
12/02/20 Cantor Fitzgerald
Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

11/10/20
Lumos Pharma reports Q3 EPS 21c, consensus (64c)
04/27/21
KOL Webinar on LUM-201
04/27/21
Lumos Pharma - LUMO
05/19/21
Lumos Pharma Inc
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

10/19/20
Six new option listings and ten option delistings on October 19th
Hot Stocks
MEI Pharma completes enrollment in Phase 2 Tidal study » 07:12
04/13/21
04/13
07:12
04/13/21
07:12
MEIP

MEI Pharma

$3.39 /

-0.04 (-1.17%)

MEI Pharma and Kyowa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

04/11/21
MEI Pharma reports preclinical data on Voruciclib ability to regulate MYC
01/04/21
MEI Pharma expands Phase 1b study evaluating zandelisib
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

02/04/21
MEI Pharma reports Q2 EPS (16c), consensus (13c)
11/10/20
MEI Pharma reports Q1 EPS (2c), consensus (8c)
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

12/03/20
Fly Intel: Pre-market Movers
Recommendations
Nvidia price target raised to $700 from $620 at Credit Suisse » 07:12
04/13/21
04/13
07:12
04/13/21
07:12
NVDA

Nvidia

$608.46 /

+33.14 (+5.76%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Nvidia announces eight new Ampere architecture GPUs
04/12/21
Cloudera up 3% to $13.01 after announcing collaboration with Nvidia
04/12/21
Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud
04/12/21
Nvidia unveils Nvidia Drive Atlan 'AI center on wheels'
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

07:08 Today Deutsche Bank
Nvidia price target raised to $575 from $560 at Deutsche Bank
06:57 Today Mizuho
Nvidia price target raised to $675 from $650 at Mizuho
06:56 Today Susquehanna
Nvidia to invest heavily into data center space, says Susquehanna
06:09 Today Barclays
Nvidia price target raised to $650 from $600 at Barclays
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B
02/24/21
Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B
02/24/21
Nvidia reports Q4 EPS $3.10, consensus $2.81
02/24/21
Notable companies reporting after market close
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

03/23/21
Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports
03/09/21
Some Xbox users can now stream Steam games through web browser, VGC says
02/12/21
Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says
02/12/21
FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Fly Intel: Wall Street's top stories for Monday
04/09/21
The Intersection: Crypto and Wall Street This Week
03/26/21
The Intersection: Crypto and Wall Street This Week
03/23/21
Game On: Microsoft in talks to buy Discord as Sony acquires EVO
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

02/25/21
NVIDIA call buyer realizes 13% same-day gains
01/11/21
Early notable gainers among liquid option names on January 11th
11/18/20
NVIDIA options imply 8.0% move in share price post-earnings
11/04/20
NVIDIA call buyer realizes 8% same-day gains
Upgrade
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11
04/13/21
04/13
07:11
04/13/21
07:11
BMY

Bristol-Myers

$62.70 /

+0.09 (+0.14%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

04/11/21
Bristol-Myers announces results from CheckMate -816 study
04/08/21
Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial
04/01/21
Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers
03/30/21
Huyabio International enters clinical collaboration agreement with Bristol-Myers
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

06:08 Today Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

03/04/21
Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c)
02/24/21
CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M
02/04/21
Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45
02/04/21
Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

04/01/21
Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports
02/15/21
Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
12/23/20
Judge rules against White House drug pricing rule, Reuters says
11/23/20
EU seeks easier access to generic medicines, Reuters says
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

03/29/21
Fly Intel: Pre-market Movers
02/09/21
Fly Intel: Pre-market Movers
12/26/20
Week in review: How Trump's policies moved stocks
11/21/20
Week in review: How Trump's policies moved stocks
04/29/21
Bristol-Myers - BMY
04/29/21
Oncologic Drugs Advisory Committee Virtual Meeting
05/20/21
PDUFA Date for CM-577 - Opdivo
05/25/21
PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo
05/30/21
PDUFA Date for Zeposia (Ozanimod)
01/28/22
PDUFA Date for Mavacamten
05/04/21
Bristol Myers Squibb Co
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

04/07/21
Unusually active option classes on open April 7th
01/20/21
Unusually active option classes on open January 20th
01/11/21
Unusually active option classes on open January 11th
01/05/21
Bristol Myers Squibb call volume above normal and directionally bullish
Recommendations
TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
TRIP

TripAdvisor

$51.17 /

-1.27 (-2.42%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

03/24/21
TripAdvisor, Reckitt announce partnership
03/22/21
TripAdvisor announces $300M convertible notes offering
02/18/21
TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20
02/18/21
TripAdvisor: January revenue performance dipped slightly relative to December
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

04/05/21 Evercore ISI
TripAdvisor assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
TripAdvisor initiated with a Peer Perform at Wolfe Research
03/12/21 Truist
TripAdvisor price target raised to $62 from $48 at Truist
03/02/21 Citi
TripAdvisor upgraded to Buy from Neutral at Citi
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

02/18/21
TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c)
02/18/21
Notable companies reporting after market close
11/06/20
TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M
11/05/20
TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c)
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

10/23/20
TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

04/01/21
Alphabet, Facebook initiations among today's top calls on Wall Street
03/02/21
Zoom Video, TripAdvisor upgrades among today's top calls
01/08/21
Another Tesla upgrade among today's top calls on Wall Street
12/02/20
Fly Intel: Pre-market Movers
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

03/24/21
Unusually active option classes on open March 24th
03/05/21
Unusually active option classes on open March 5th
03/03/21
TripAdvisor call volume above normal and directionally bullish
02/26/21
TripAdvisor call volume above normal and directionally bullish
Hot Stocks
Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
BHC

Bausch Health

$29.93 /

-0.86 (-2.79%)

Bausch + Lomb, a global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

04/07/21
Bausch Health's ClearVisc viscosurgical device approved by FDA
03/31/21
Bausch Health to sell Amoun Pharmaceuticals to ADQ for about $740M
03/11/21
Bausch Health appoints Sam Eldessouky as CFO effective June 1
02/26/21
Bausch Health to reduce debt by $100M
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

03/24/21
Fly Intel: Top five analyst downgrades
03/24/21 BofA
BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection'
03/24/21 BofA
Bausch Health downgraded to Underperform from Neutral at BofA
03/16/21 H.C. Wainwright
Bausch Health price target raised to $55 from $50 at H.C. Wainwright
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

02/24/21
Bausch Health sees FY21 revenue $8.6B-$8.8B, consensus $8.5B
02/24/21
Bausch Health reports Q4 revenue $2.21B, consensus $2.17B
01/12/21
Bausch Health sees Q4 revenue over $2.20B, consensus $2.12B
11/03/20
Bausch Health reports Q3 adjusted EBITDA $948M, consensus $844.9M
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

12/29/20
Fly Intel: Pre-market Movers
11/03/20
Fly Intel: Pre-market Movers
05/04/21
Bausch Health - BHC
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

03/09/21
Bausch Health call volume above normal and directionally bullish
03/03/21
Bausch Health put volume heavy and directionally bearish
01/05/21
Bausch Health call volume above normal and directionally bullish
01/04/21
Bausch Health call volume above normal and directionally bullish
Recommendations
Expedia price target raised to $175 from $145 at Jefferies » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
EXPE

Expedia

$171.77 /

-3.14 (-1.80%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

02/11/21
Expedia sees Q1 adjusted EBITDA down significantly.
02/11/21
Expedia reports Q4 room night growth down 61%
12/08/20
Porch.com appoints Matthew Cullen as general counsel, secretary
11/13/20
Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

04/05/21 Evercore ISI
Expedia assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
Expedia initiated with a Peer Perform at Wolfe Research
03/30/21 Gordon Haskett
Expedia initiated with a Buy at Gordon Haskett
03/25/21 Morgan Stanley
Expedia price target raised to $200 from $160 at Morgan Stanley
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

02/11/21
Expedia reports Q4 adjusted EPS ($2.64), consensus ($1.97)
02/11/21
Notable companies reporting after market close
11/04/20
Expedia reports Q3 adjusted EPS (22c), consensus (79c)
11/04/20
Notable companies reporting after market close
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

04/08/21
Expedia adds tool to check Covid restrictions amid travel lust, The Verge says
11/20/20
Tech giants threaten to exit Pakistan over censorship law, TechCrunch says
10/23/20
TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

04/01/21
Alphabet, Facebook initiations among today's top calls on Wall Street
03/30/21
Alphabet, Roku upgrades among today's top calls on Wall Street
02/12/21
Fly Intel: Wall Street's top stories for Friday
02/12/21
Fly Intel: Wall Street's top stories at midday
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

04/07/21
Expedia call volume above normal and directionally bullish
02/03/21
Unusually active option classes on open February 3rd
01/25/21
Expedia call volume above normal and directionally bullish
12/16/20
Expedia call volume above normal and directionally bullish
Hot Stocks
Extreme Networks appoints John Abel as CFO » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
EXTR

Extreme Networks

$9.47 /

+0.06 (+0.64%)

Extreme Networks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

02/17/21
Extreme Networks selected by MLB as official wi-fi solutions provider
10/28/20
Extreme Networks sees Q2 adjusted gross margin 60%-60.6%
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

02/24/21 Lake Street
Extreme Networks price target raised to $12 from $8 at Lake Street
02/10/21 B. Riley Securities
Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities
01/28/21 Lake Street
Extreme Networks price target raised to $8 from $6 at Lake Street
01/28/21 B. Riley Securities
Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

02/09/21
Extreme Networks backs Q3 adjusted EPS view 11c-16c, consensus 13c
02/09/21
Extreme Networks reports Q2 adjusted EPS 13c, consensus 14c
01/27/21
Extreme Networks sees Q2 non-GAAP EPS 11c-17c, consensus 11c
01/27/21
Extreme Networks sees Q3 non-GAAP EPS 11c-16c, consensus 8c
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

01/27/21
Fly Intel: After-Hours Movers
05/24/21
Global Technology, Media & Communications Virtual Conference
Recommendations
Nasdaq price target raised to $164 from $160 at Deutsche Bank » 07:09
04/13/21
04/13
07:09
04/13/21
07:09
NDAQ

Nasdaq

$156.17 /

+0.15 (+0.10%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

03/16/21
PureStream Trading Technologies selects Nasdaq to power its ATS
02/08/21
Nasdaq gets Investment Canada Act approval for Verafin, acquisition
02/02/21
Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M
02/02/21
Nasdaq to sell U.S. fixed income business to Tradeweb Markets
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

04/09/21 UBS
Nasdaq price target raised to $178 from $170 at UBS
04/08/21 Piper Sandler
Nasdaq price target raised to $165 from $160 at Piper Sandler
01/29/21 Citi
Nasdaq price target raised to $147 from $144 at Citi
01/28/21 Barclays
Nasdaq price target raised to $160 from $155 at Barclays
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

01/27/21
Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45
10/21/20
Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

03/05/21
Robinhood picks Nasdaq for eventual IPO, CNBC reports
02/12/21
Senate Republicans urge SEC to reject Nasdaq diversity rules, Reuters reports
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

03/05/21
Fly Intel: Wall Street's top stories for Friday
11/19/20
Fly Intel: Wall Street's top stories for Thursday
11/19/20
Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth
11/19/20
Fly Intel: Wall Street's top stories at midday
04/21/21
Nasdaq - NDAQ
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

12/07/20
Early notable gainers among liquid option names on December 7th
Upgrade
Booking Holdings upgraded to Buy on coming travel rebound at Jefferies » 07:09
04/13/21
04/13
07:09
04/13/21
07:09
BKNG

Booking Holdings

$2,409.04 /

-30.64 (-1.26%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

03/25/21
JetBlue announces launch of Paisly by JetBlue, a new travel website
02/24/21
Booking Holdings CEO says 'more confident than ever' in eventual travel recovery
02/16/21
Lone Pine bought Snap and Carvana during Q4, exited PayPal
11/16/20
Lone Pine buys Square, exits Visa in Q3
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

06:48 Today Jefferies
Booking Holdings upgraded to Buy from Hold at Jefferies
04/05/21 Evercore ISI
Booking Holdings assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
Booking Holdings initiated with an Outperform at Wolfe Research
03/30/21 Gordon Haskett
Booking Holdings initiated with a Hold at Gordon Haskett
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

02/24/21
Booking Holdings reports Q4 adjusted EPS (57c), consensus ($4.28)
02/24/21
Notable companies reporting after market close
11/05/20
Booking CEO says COVID-19 surge to impact travel in near-term
11/05/20
Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

04/01/21
Alphabet, Facebook initiations among today's top calls on Wall Street
03/30/21
Alphabet, Roku upgrades among today's top calls on Wall Street
03/22/21
Snap downgrade, PepsiCo upgrade among today's top calls on Wall Street
01/04/21
Airbnb under pressure as Wall Street analysts roll out coverage following IPO
05/24/21
Global Technology, Media & Communications Virtual Conference
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

01/04/21
Booking Holdings put volume heavy and directionally bearish
Downgrade
Idacorp downgraded to Neutral from Buy at BofA » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
IDA

Idacorp

$100.06 /

+0.49 (+0.49%)

BofA analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDA Idacorp
$100.06 /

+0.49 (+0.49%)

01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
01/06/21 Wells Fargo
Idacorp downgraded to Underweight from Equal Weight at Wells Fargo
05/04/20 Sidoti
Idacorp upgraded to Buy on valuation at Sidoti
05/04/20 Sidoti
Idacorp upgraded to Buy from Neutral at Sidoti
IDA Idacorp
$100.06 /

+0.49 (+0.49%)

02/18/21
Idacorp sees FY21 EPS $.60-$4.80, consensus $4.75
02/18/21
Idacorp reports Q4 EPS 74c, consensus 67c
04/29/21
Idacorp - IDA
05/20/21
IDACORP, Inc.
Hot Stocks
Evogene's Biomica demonstrates efficacy of BMC128 in studies » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
EVGN

Evogene

$4.37 /

-0.26 (-5.62%)

Biomica, a subsidiary of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVGN Evogene
$4.37 /

-0.26 (-5.62%)

03/25/21
Evogene subsidiary, Tikun Olam-Cannbit enter pact for cannabis distribution
03/17/21
Evogene's Ag-Seed division, Plastomics enter collaborative agreement
02/24/21
Evogene subsidiary, Cannbit enter collaboration for medical cannabis products
12/29/20
Lavie Bio targets product launch for LAV311, LAV312 in 2024
EVGN Evogene
$4.37 /

-0.26 (-5.62%)

11/30/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight
11/30/20 Cantor Fitzgerald
Evogene initiated with an Overweight at Cantor Fitzgerald
04/21/21
Evogene Ltd.
EVGN Evogene
$4.37 /

-0.26 (-5.62%)

02/03/21
new option listings on February 3rd
Recommendations
Nvidia price target raised to $575 from $560 at Deutsche Bank » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
NVDA

Nvidia

$608.46 /

+33.14 (+5.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Nvidia announces eight new Ampere architecture GPUs
04/12/21
Cloudera up 3% to $13.01 after announcing collaboration with Nvidia
04/12/21
Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud
04/12/21
Nvidia unveils Nvidia Drive Atlan 'AI center on wheels'
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

06:57 Today Mizuho
Nvidia price target raised to $675 from $650 at Mizuho
06:56 Today Susquehanna
Nvidia to invest heavily into data center space, says Susquehanna
06:09 Today Barclays
Nvidia price target raised to $650 from $600 at Barclays
04/12/21 Lynx
Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B
02/24/21
Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B
02/24/21
Nvidia reports Q4 EPS $3.10, consensus $2.81
02/24/21
Notable companies reporting after market close
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

03/23/21
Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports
03/09/21
Some Xbox users can now stream Steam games through web browser, VGC says
02/12/21
Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says
02/12/21
FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/12/21
Fly Intel: Wall Street's top stories for Monday
04/09/21
The Intersection: Crypto and Wall Street This Week
03/26/21
The Intersection: Crypto and Wall Street This Week
03/23/21
Game On: Microsoft in talks to buy Discord as Sony acquires EVO
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

02/25/21
NVIDIA call buyer realizes 13% same-day gains
01/11/21
Early notable gainers among liquid option names on January 11th
11/18/20
NVIDIA options imply 8.0% move in share price post-earnings
11/04/20
NVIDIA call buyer realizes 8% same-day gains
Syndicate
Liquidia Technologies announces $21.7M private placement » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
LQDA

Liquidia Technologies

$2.53 /

-0.05 (-1.94%)

Liquidia Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

03/30/21
Liquidia's generic Treprostinil injection can be given subcutaneously
03/23/21
Liquidia Technologies intends to submit response to FDA CRL in mid-2021
03/23/21
Liquidia Technologies initiates actions to reduce net annual cash spending
03/02/21
Liquidia Technologies secures $20.5M debt facility with Silicon Valley Bank
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

12/04/20
Fly Intel: Top five analyst initiations
12/04/20 H.C. Wainwright
Liquidia Technologies initiated with a Buy at H.C. Wainwright
11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Wedbush
Liquidia Technologies downgraded to Neutral from Outperform at Wedbush
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

03/23/21
Liquidia Technologies reports 2020 EPS ($1.76), consensus ($1.74)
11/09/20
Liquidia Technologies reports Q3 EPS (40c), two est. (36c)
  • 30
    Jun
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

11/03/20
Largest borrow rate increases among liquid names
10/30/20
Largest borrow rate increases among liquid names
10/28/20
Largest borrow rate increases among liquid names
Hot Stocks
Rigel announces results from Phase 2 clinical trial of fostamatinib » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
RIGL

Rigel Pharmaceuticals

$3.10 /

-0.155 (-4.77%)

Rigel Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

04/07/21
Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly
03/11/21
Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib
02/18/21
Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552
01/29/21
Rigel announces award of $16.5M from DOD for fostamatinib trial in COVID-19
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
11/09/20
Fly Intel: Top five analyst downgrades
11/09/20 JPMorgan
Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

03/02/21
Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c)
01/11/21
Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M
11/05/20
Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c)
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

01/15/21
Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says
05/18/21
Rigel Pharmaceuticals Inc.
Hot Stocks
Castle Biosciences says DecisionDx-Melanoma is significant predictor of outcomes » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
CSTL

Castle Biosciences

$67.54 /

-1.9 (-2.74%)

Castle Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

01/13/21
Castle Biosciences delivered 5,157 gene expression profile test reports in Q4
12/04/20
Castle Biosciences publishes DecisionDx-Melanoma clinical use study
11/17/20
Castle Biosciences announces publication of two studies in SKIN
11/12/20
Castle Biosciences presents data for melanoma tests at ASDP
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
01/15/21 SVB Leerink
Castle Biosciences price target raised to $80 from $70 at SVB Leerink
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

03/08/21
Castle Biosciences reports Q4 EPS (23c), consensus (12c)
11/09/20
Castle Biosciences reports Q3 EPS (23c), consensus (11c)
  • 16
    Dec
  • 25
    Jun
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

03/08/21
Fly Intel: After-Hours Movers
Initiation
Truist starts Instil Bio with a Buy citing efficacy in solid tumors » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
TIL

Instil Bio

$22.13 /

+0.05 (+0.23%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

04/12/21
Instil Bio presents clinical data for metastatic melanoma at 2021 AACR meeting
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

06:18 Today Truist
Instil Bio initiated with a Buy at Truist
06:00 Today Cowen
Instil Bio initiated with an Outperform at Cowen
05:59 Today Morgan Stanley
Instil Bio initiated with an Equal Weight at Morgan Stanley
  • 19
    Mar
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

03/20/21
Opening Day: China's Tuya raised $915M in U.S. IPO
Hot Stocks
Versus Systems' adds functionality to prizing engine to support uses in India » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
VRSSF

Versus Systems

/

+

Versus Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    HCA Healthcare price target raised to $210 from $180 at Deutsche Bank » 07:07
    04/13/21
    04/13
    07:07
    04/13/21
    07:07
    HCA

    HCA Healthcare

    $191.65 /

    +0.54 (+0.28%)

    Deutsche Bank analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    02/24/21
    Brookdale Senior Living to sell 80% stake in BHS to HCA Healthcare for $400M
    01/26/21
    HCA Healthcare uses Its COVID-19 registry to aid research in area
    01/21/21
    HCA Healthcare in new JV with A Plus International to expand PPE access
    10/26/20
    HCA Healthcare sees FY21 EBITDA $10.25B-$10.65B
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    04/09/21 Mizuho
    HCA Healthcare price target raised to $205 from $195 at Mizuho
    02/05/21 Mizuho
    HCA Healthcare price target raised to $195 from $180 at Mizuho
    02/04/21
    HCA Healthcare price target raised to $203 from $164 at UBS
    02/03/21 Citi
    HCA Healthcare price target raised to $191 from $185 at Citi
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    02/02/21
    HCA Healthcare sees FY21 EPS $12.10 to $13.10, consensus $11.95
    02/02/21
    HCA Healthcare reports Q4 EPS $4.13, consensus $3.60
    10/26/20
    HCA Healthcare reports Q3 ex-items EPS $1.92, consensus $2.32
    10/26/20
    HCA Healthcare reports Q3 EPS $1.95, consensus $2.32
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    11/10/20
    Supreme Court appears unlikely to topple ACA, USA Today says
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    02/02/21
    Fly Intel: Pre-market Movers
    11/14/20
    Week in review: How Trump's policies moved stocks
    05/24/21
    Global Healthcare Virtual Conference 2021
    04/22/21
    HCA Healthcare - HCA
    04/28/21
    HCA Healthcare, Inc.
    Syndicate
    Bally's announces commencement of stock, tangible equity unit offerings » 07:07
    04/13/21
    04/13
    07:07
    04/13/21
    07:07
    BALY

    Bally's

    $60.79 /

    -0.885 (-1.43%)

    , JKPTF

    Gamesys Group

    $27.00 /

    + (+0.00%)

    Bally's Corporation…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    07:05 Today
    Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties
    05:26 Today
    Bally's to combine with Gamesys Group
    04/12/21
    Bally's announces agreement with Sinclair Broadcast
    03/25/21
    Allied Esports Entertainment determines Bally's proposal superior to Element's
    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    05:26 Today
    Bally's to combine with Gamesys Group
    03/24/21
    Bally's reports agreement in principle to buy Gamesys Group plc
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/08/21 KeyBanc
    Bally's price target raised to $70 from $65 at KeyBanc
    03/29/21 Truist
    Early March casino data looks 'very positive,' says Truist
    03/25/21 Stifel
    Bally's price target raised to $75 from $70 at Stifel
    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    03/16/21 Jefferies
    Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
    03/10/21 Berenberg
    Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
    03/10/21 Deutsche Bank
    Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    07:03 Today
    Bally's sees Q1 revenue $185M, consensus $156.45M
    03/04/21
    Bally's reports Q4 adjusted EPS 39c, consensus (8c)
    11/09/20
    Bally's Corporation changes name from Twin River Worldwide Holdings
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    03/10/21
    Casino companies prepare to compete for NYC-area license, NY Post reports
    01/21/21
    Japan expects Tokyo Olympics will have to be cancelled, The Times says
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/09/21
    Bet On It: Mobile sports betting added to budget in New York
    04/01/21
    Bet On It: Sports betting operators make more content-related deals
    03/26/21
    Bet On It: Las Vegas recovery potentially underway as restrictions loosen
    03/24/21
    Fly Intel: Wall Street's top stories for Wednesday
    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    03/24/21
    Fly Intel: Wall Street's top stories for Wednesday
    03/24/21
    Fly Intel: Wall Street's top stories at midday
    05/18/21
    Bally's Corporation
    Recommendations
    ArcelorMittal price target raised to $36 from $30 at Deutsche Bank » 07:06
    04/13/21
    04/13
    07:06
    04/13/21
    07:06
    MT

    ArcelorMittal

    $28.95 /

    -0.02 (-0.07%)

    Deutsche Bank analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    04/08/21
    Infosys announces collaboration with ArcelorMittal
    04/01/21
    Societe Generale increases shareholding in ArcelorMittal
    03/17/21
    Air Liquide, ArcelorMittal sign MOU to contribute to decarbonization of Dunkirk
    02/11/21
    ArcelorMittal CEO to become executive chairman, Aditya Mittal to succeed
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    04/12/21 UBS
    ArcelorMittal price target raised to EUR 30 from EUR 25 at UBS
    04/09/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 28.50 from EUR 28 at Morgan Stanley
    03/24/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 28 from EUR 24 at Morgan Stanley
    02/22/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 24 from EUR 23 at Morgan Stanley
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    11/05/20
    ArcelorMittal reports Q3 EPS (21c), two estimates (17c)
    • 12
      May
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    03/24/21
    Steel complex lobbies Biden administration on Trump tariffs, Bloomberg says
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    04/09/21
    Unusually active option classes on open April 9th
    04/08/21
    Unusually active option classes on open April 8th
    04/07/21
    ArcelorMittal call volume above normal and directionally bullish
    03/31/21
    ArcelorMittal call volume above normal and directionally bullish
    Hot Stocks
    Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties » 07:05
    04/13/21
    04/13
    07:05
    04/13/21
    07:05
    BALY

    Bally's

    $60.79 /

    -0.885 (-1.43%)

    , GLPI

    Gaming and Leisure Properties

    $43.37 /

    +0.11 (+0.25%)

    Bally's (BALY)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    05:26 Today
    Bally's to combine with Gamesys Group
    04/12/21
    Bally's announces agreement with Sinclair Broadcast
    03/25/21
    Allied Esports Entertainment determines Bally's proposal superior to Element's
    03/25/21
    Bally's Richmond Casino Resort selected as one of three finalists in Virginia
    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    01/07/21
    Gaming and Leisure Properties promotes Steven Ladany to CDO
    01/05/21
    Gaming and Leisure Properties appoints Matthew Demchyk to CIO
    12/15/20
    Penn National to acquire Hollywood Casino Perryville from GLPI for $31.1M
    12/15/20
    Gaming and Leisure Properties reports sale and lease transactions
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/08/21 KeyBanc
    Bally's price target raised to $70 from $65 at KeyBanc
    03/29/21 Truist
    Early March casino data looks 'very positive,' says Truist
    03/25/21 Stifel
    Bally's price target raised to $75 from $70 at Stifel
    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    03/31/21 Mizuho
    Gaming and Leisure Properties initiated with a Buy at Mizuho
    03/15/21
    Fly Intel: Top five analyst initiations
    03/15/21 KeyBanc
    Gaming and Leisure Properties initiated with an Overweight at KeyBanc
    02/22/21 Deutsche Bank
    Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    07:03 Today
    Bally's sees Q1 revenue $185M, consensus $156.45M
    03/04/21
    Bally's reports Q4 adjusted EPS 39c, consensus (8c)
    11/09/20
    Bally's Corporation changes name from Twin River Worldwide Holdings
    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    02/18/21
    Gaming and Leisure Properties reports Q4 FFO 85c, consensus 85c
    10/27/20
    Gaming and Leisure Propertiesl Partners reports Q3 FFO 89c, consensus 85c
    • 30
      Oct
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    03/10/21
    Casino companies prepare to compete for NYC-area license, NY Post reports
    01/21/21
    Japan expects Tokyo Olympics will have to be cancelled, The Times says
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/09/21
    Bet On It: Mobile sports betting added to budget in New York
    04/01/21
    Bet On It: Sports betting operators make more content-related deals
    03/26/21
    Bet On It: Las Vegas recovery potentially underway as restrictions loosen
    03/24/21
    Fly Intel: Wall Street's top stories for Wednesday
    04/30/21
    Gaming and Leisure Properties - GLPI
    05/18/21
    Bally's Corporation
    Hot Stocks
    908 Devices appoints Michele Fournier as Chief People Officer » 07:04
    04/13/21
    04/13
    07:04
    04/13/21
    07:04
    MASS

    908 Devices

    $50.85 /

    +1.05 (+2.11%)

    908 Devices announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    04/08/21
    908 Devices announces MX908 solution selected by U.S. Border Patrol
    03/30/21
    908 Devices awarded $25M purchase order by U.S. Army
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    01/12/21 SVB Leerink
    908 Devices initiated with an Outperform at SVB Leerink
    01/12/21 Cowen
    Cowen starts 908 Devices at Outperform, sees 'mass-ive opportunity'
    01/12/21 William Blair
    908 Devices initiated with an Outperform at William Blair
    01/12/21 SVB Leerink
    908 Devices initiated with an Outperform at SVB Leerink
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    03/30/21
    908 Devices sees 2021 revenue $38M-$40M, consensus $39.19M
    03/30/21
    908 Devices reports Q4 EPS ($1.48), consensus (16c)
    • 18
      Dec
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    12/20/20
    Opening Day: Upstart, Wish make trading debuts
    Downgrade
    StoneCo assumed with a Neutral from Buy at Citi » 07:04
    04/13/21
    04/13
    07:04
    04/13/21
    07:04
    STNE

    StoneCo

    $67.72 /

    -0.05 (-0.07%)

    Citi analyst Gabriel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    STNE StoneCo
    $67.72 /

    -0.05 (-0.07%)

    01/14/21
    StoneCo raises funding for credit solution for SMBs in Brazil
    11/17/20
    StoneCo raises cash portion of consideration for Linx by R$1.50 per share
    11/16/20
    Lone Pine buys Square, exits Visa in Q3
    10/29/20
    StoneCo waives certain breakup fees, increases cash portion in Linx combination
    STNE StoneCo
    $67.72 /

    -0.05 (-0.07%)

    03/17/21 Grupo Santander
    StoneCo upgraded to Hold from Underperform at Grupo Santander
    03/12/21 HSBC
    StoneCo upgraded to Buy from Hold at HSBC
    02/05/21 Credit Suisse
    StoneCo upgraded to Outperform from Neutral at Credit Suisse
    01/29/21
    Fly Intel: Top five analyst initiations
    STNE StoneCo
    $67.72 /

    -0.05 (-0.07%)

    03/11/21
    StoneCo reports Q4 adjusted EPS R$1.16 vs. R$0.97 last year
    10/29/20
    StoneCo reports Q3 adj. EPS R$0.99 vs. R$0.71 last year
    • 13
      Aug
    STNE StoneCo
    $67.72 /

    -0.05 (-0.07%)

    03/11/21
    Fly Intel: After-Hours Movers
    10/29/20
    Fly Intel: After-Hours Movers
    05/24/21
    Global Technology, Media & Communications Virtual Conference
    STNE StoneCo
    $67.72 /

    -0.05 (-0.07%)

    04/12/21
    StoneCo put volume heavy and directionally bearish
    01/20/21
    Unusual call flow in option market yesterday
    01/19/21
    Stone cold call seller in StoneCo
    Hot Stocks
    Apellis provides 24-month update from phase 1b study of pegcetacoplan » 07:03
    04/13/21
    04/13
    07:03
    04/13/21
    07:03
    APLS

    Apellis

    $41.60 /

    +0.08 (+0.19%)

    Apellis announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    APLS Apellis
    $41.60 /

    +0.08 (+0.19%)

    03/17/21
    Apellis discloses NEJM study demonstrating pegcetacoplan superiority in PNH
    03/04/21
    Apellis to discontinue development of APL-9 following DMC review
    01/21/21
    Apellis says 'on track' for Phase 3 GA results in 3Q21
    12/10/20
    Swedish Orphan Biovitrum, Apellis report results from PEGASUS study
    APLS Apellis
    $41.60 /

    +0.08 (+0.19%)

    03/29/21 JPMorgan
    Apellis added to Analyst Focus List with $87 target at JPMorgan
    01/29/21 Baird
    Apellis assumed at Outperform at Baird
    12/14/20 Roth Capital
    Apellis price target raised to $73 from $50 at Roth Capital
    12/10/20 Cowen
    Apellis price target raised to $55 from $45 at Cowen
    APLS Apellis
    $41.60 /

    +0.08 (+0.19%)

    02/25/21
    Apellis reports Q EPS 93c, consensus (75c)
    11/02/20
    Apellis reports Q3 EPS ($1.79), consensus ($1.58)
    APLS Apellis
    $41.60 /

    +0.08 (+0.19%)

    12/14/20
    Fly Intel: Wall Street's top stories for Monday
    12/14/20
    Fly Intel: Wall Street's top stories at midday
    05/14/21
    PDUFA Date for Pegcetacoplan

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.